Advanced Pancreatic Cancer Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Hangzhou Converd Co., Ltd.12 enrolled1 locationNCT07006077
Recruiting
Phase 2
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
Advanced Pancreatic Cancers
Zhejiang University64 enrolled2 locationsNCT06770439